Latest Biologic Stories
Dr. Daniel M. Takefman brings 15 years of FDA experience to leading gene therapy company PHILADELPHIA, Nov.
DALLAS, November 21, 2014 /PRNewswire/ -- ReportsnReports.com adds Global Oncology Biosimilars Market 2014-2018 industry research report of 71 pages to the life science
MIAMI, Nov. 18, 2014 /PRNewswire/ -- Vivex Biomedical, Inc.
Treatment for lifelong skin disease that affects nearly a million Canadians showed significant and clinically meaningful improvements in clinical studies Canadian approval comes
Study finds that the Solstice-licensed technology allows efficient delivery of RNAi prodrugs SAN DIEGO, Nov.
EDISON, N.J., Nov.
Sales of Biologics Will Contribute Approximately $2.3 Billion to the UC Market in 2023, According to Findings from Decision Resources Group BURLINGTON, Mass., Nov.
- Growing in low tufty patches.